Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
April 28, 2021 at 11:03 am EDT
Share
Chimin Health Management Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 877.640 million compared to CNY 771.279 million a year ago. Operating income was CNY 31.487 million compared to CNY 90.722 million a year ago. Net income was CNY 6.397 million compared to CNY 69.198 million a year ago. Basic earnings per share from continuing operations was CNY 0.02 compared to CNY 0.22 a year ago.
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
CHIMIN HEALTH MANAGEMENT CO., LTD. 
